IS, T., R, D., A, I., JA, K., N, T., KM, S., . . . AH, W. (2021). Clinical impact of NPM1-mutant molecular persistence after chemotherapy for acute myeloid leukemia. Blood advances, 5(23), 5107. https://doi.org/10.1182/bloodadvances.2021005455
Chicago Style (17th ed.) CitationIS, Tiong, et al. "Clinical Impact of NPM1-mutant Molecular Persistence After Chemotherapy for Acute Myeloid Leukemia." Blood Advances 5, no. 23 (2021): 5107. https://doi.org/10.1182/bloodadvances.2021005455.
MLA (9th ed.) CitationIS, Tiong, et al. "Clinical Impact of NPM1-mutant Molecular Persistence After Chemotherapy for Acute Myeloid Leukemia." Blood Advances, vol. 5, no. 23, 2021, p. 5107, https://doi.org/10.1182/bloodadvances.2021005455.
Warning: These citations may not always be 100% accurate.
